me-check®
me-check® is Espansione's diagnostic and screening platform. Where the therapeutic devices treat dry eye and related conditions, me-check® is the tool that helps identify and characterise them, bringing the discipline that the TFOS DEWS III diagnostic pathway calls for into one place. See its role in screening.
What it captures
me-check® supports the core measurements a modern dry eye workup depends on, including meibography, imaging of the meibomian glands, and the OSDI-6 symptom questionnaire. Capturing these in one consistent record makes the diagnose-then-classify workflow practical in a busy clinic, feeding the driver-based subclassification that steers treatment.
Why screening matters
DEWS III draws a clear line: screen with a simple questionnaire, confirm with a single sign, and never skip ocular surface staining (TFOS DEWS III, 2025, American Journal of Ophthalmology). A platform that carries much of this load reduces the drift of an inconsistent, many-test routine into a repeatable pathway. The meibography image is also one of the most powerful tools for engaging patients, who often commit to treatment once they see the state of their own glands.
Where it fits in the line-up
me-check® is the front door to care: it identifies who needs treatment and characterises the drivers, which then guides whether eye-light® or meibomask® and which protocol is appropriate. For the full diagnostic logic, see the dry eye workup.
Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.